Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_3
4
44%
Ph phase_1
4
44%
Ph phase_2
1
11%

Phase Distribution

4

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (44.4%)
Phase 21 (11.1%)
Phase 34 (44.4%)

Trials by Status

withdrawn111%
completed889%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

NCT05299554
completedphase_3

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

NCT05063994
completedphase_2

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

NCT05222152
completedphase_1

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

NCT00519818
withdrawnphase_3

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

NCT03532022
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05299554Phase 3

Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

Completed
NCT05063994Phase 3

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

Completed
NCT05222152Phase 2

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

Completed
NCT00519818Phase 1

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

Completed
NCT03532022Phase 3

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

Withdrawn
NCT02716818Phase 3

Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia

Completed
NCT03343327Phase 1

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

Completed
NCT03051893Phase 1

A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations

Completed
NCT03019614Phase 1

An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9